APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sterile Injectable CDMO

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sterile Injectable CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 January 2026198 pages

Choose your research edition.

Industry ResearchSterile Injectable CDMO Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Sterile Injectable CDMO Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Sterile Injectable CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sterile Injectable CDMO Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Sterile Injectable CDMO Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Sterile Injectable CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Sterile Injectable CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sterile Injectable CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sterile Injectable CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sterile Injectable CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sterile Injectable CDMO include Abbvie, Famar, Polfa Tarchomin, Pfizer, Quotient Sciences, Temad Co., Tianjin Hankang Pharmaceutical Biotechnology, Fareva and Sharp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Sterile Injectable CDMO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sterile Injectable CDMO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sterile Injectable CDMO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Sterile Injectable CDMO market size, projected growth trends, production technologies, key applications, and end-use industries.

Sterile Injectable CDMO Segment by Company

Abbvie

Famar

Polfa Tarchomin

Pfizer

Quotient Sciences

Temad Co.

Tianjin Hankang Pharmaceutical Biotechnology

Fareva

Sharp

Astral SteriTech

Evonik

Aurigene Pharmaceutical Services

Prague Scientific

Ethypharm

TriRx Pharmaceutical Services

Biophrama Group

Gensenta Pharmaceuticals

BioTechnique

Mithra CDMo

S.C. Rompharm Company SRL

Flagship Biotech International Pvt. Ltd

Curida AS

BirgiMefar Group

Brooks Laboratories Limited

Sterile Injectable CDMO Segment by Type

Preclinical Manufacturing

Clinical Manufacturing

Commercial Manufacturing

Sterile Injectable CDMO Segment by Application

Pharmaceutical Company

Research Institute

Other

Sterile Injectable CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sterile Injectable CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sterile Injectable CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sterile Injectable CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Sterile Injectable CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sterile Injectable CDMO industry.

Chapter 3: Detailed analysis of Sterile Injectable CDMO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sterile Injectable CDMOrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sterile Injectable CDMO Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Preclinical Manufacturing Table 3. Key Players of Clinical Manufacturing Table 4. Key Players of Commercial Manufacturing Table 4. Global Sterile Injectable CDMO Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Company Table 6. Key Players of Research Institute Table 7. Key Players of Other Table 8. Global Sterile Injectable CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Sterile Injectable CDMO Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Sterile Injectable CDMO Market Share by Region (2021-2026) Table 11. Global Sterile Injectable CDMO Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Sterile Injectable CDMO Market Share by Region (2027-2032) Table 13. Sterile Injectable CDMO Industry Trends Table 14. Sterile Injectable CDMO Industry Drivers Table 15. Sterile Injectable CDMO Industry Opportunities and Challenges Table 16. Sterile Injectable CDMO Industry Restraints Table 17. Global Sterile Injectable CDMO Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Sterile Injectable CDMO Revenue Market Share by Company (2021-2026) Table 19. Global Sterile Injectable CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Sterile Injectable CDMO Key Company Head Office and Area Served Table 21. Global Sterile Injectable CDMO Company, Product Type & Application Table 22. Global Sterile Injectable CDMO Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Sterile Injectable CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Sterile Injectable CDMO Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sterile Injectable CDMO Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Sterile Injectable CDMO Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Sterile Injectable CDMO Revenue Market Share by Type (2021-2026) Table 29. Global Sterile Injectable CDMO Revenue Market Share by Type (2027-2032) Table 30. Global Sterile Injectable CDMO Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Sterile Injectable CDMO Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Sterile Injectable CDMO Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Sterile Injectable CDMO Revenue Market Share by Application (2021-2026) Table 34. Global Sterile Injectable CDMO Revenue Market Share by Application (2027-2032) Table 35. Abbvie Company Information Table 36. Abbvie Business Overview Table 37. Abbvie Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Abbvie Sterile Injectable CDMO Product Portfolio Table 39. Abbvie Recent Development Table 40. Famar Company Information Table 41. Famar Business Overview Table 42. Famar Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Famar Sterile Injectable CDMO Product Portfolio Table 44. Famar Recent Development Table 45. Polfa Tarchomin Company Information Table 46. Polfa Tarchomin Business Overview Table 47. Polfa Tarchomin Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Polfa Tarchomin Sterile Injectable CDMO Product Portfolio Table 49. Polfa Tarchomin Recent Development Table 50. Pfizer Company Information Table 51. Pfizer Business Overview Table 52. Pfizer Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pfizer Sterile Injectable CDMO Product Portfolio Table 54. Pfizer Recent Development Table 55. Quotient Sciences Company Information Table 56. Quotient Sciences Business Overview Table 57. Quotient Sciences Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Quotient Sciences Sterile Injectable CDMO Product Portfolio Table 59. Quotient Sciences Recent Development Table 60. Temad Co. Company Information Table 61. Temad Co. Business Overview Table 62. Temad Co. Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Temad Co. Sterile Injectable CDMO Product Portfolio Table 64. Temad Co. Recent Development Table 65. Tianjin Hankang Pharmaceutical Biotechnology Company Information Table 66. Tianjin Hankang Pharmaceutical Biotechnology Business Overview Table 67. Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Product Portfolio Table 69. Tianjin Hankang Pharmaceutical Biotechnology Recent Development Table 70. Fareva Company Information Table 71. Fareva Business Overview Table 72. Fareva Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Fareva Sterile Injectable CDMO Product Portfolio Table 74. Fareva Recent Development Table 75. Sharp Company Information Table 76. Sharp Business Overview Table 77. Sharp Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Sharp Sterile Injectable CDMO Product Portfolio Table 79. Sharp Recent Development Table 80. Astral SteriTech Company Information Table 81. Astral SteriTech Business Overview Table 82. Astral SteriTech Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Astral SteriTech Sterile Injectable CDMO Product Portfolio Table 84. Astral SteriTech Recent Development Table 85. Evonik Company Information Table 86. Evonik Business Overview Table 87. Evonik Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Evonik Sterile Injectable CDMO Product Portfolio Table 89. Evonik Recent Development Table 90. Aurigene Pharmaceutical Services Company Information Table 91. Aurigene Pharmaceutical Services Business Overview Table 92. Aurigene Pharmaceutical Services Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Aurigene Pharmaceutical Services Sterile Injectable CDMO Product Portfolio Table 94. Aurigene Pharmaceutical Services Recent Development Table 95. Prague Scientific Company Information Table 96. Prague Scientific Business Overview Table 97. Prague Scientific Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Prague Scientific Sterile Injectable CDMO Product Portfolio Table 99. Prague Scientific Recent Development Table 100. Ethypharm Company Information Table 101. Ethypharm Business Overview Table 102. Ethypharm Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Ethypharm Sterile Injectable CDMO Product Portfolio Table 104. Ethypharm Recent Development Table 105. TriRx Pharmaceutical Services Company Information Table 106. TriRx Pharmaceutical Services Business Overview Table 107. TriRx Pharmaceutical Services Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. TriRx Pharmaceutical Services Sterile Injectable CDMO Product Portfolio Table 109. TriRx Pharmaceutical Services Recent Development Table 110. Biophrama Group Company Information Table 111. Biophrama Group Business Overview Table 112. Biophrama Group Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Biophrama Group Sterile Injectable CDMO Product Portfolio Table 114. Biophrama Group Recent Development Table 115. Gensenta Pharmaceuticals Company Information Table 116. Gensenta Pharmaceuticals Business Overview Table 117. Gensenta Pharmaceuticals Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Gensenta Pharmaceuticals Sterile Injectable CDMO Product Portfolio Table 119. Gensenta Pharmaceuticals Recent Development Table 120. BioTechnique Company Information Table 121. BioTechnique Business Overview Table 122. BioTechnique Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. BioTechnique Sterile Injectable CDMO Product Portfolio Table 124. BioTechnique Recent Development Table 125. Mithra CDMo Company Information Table 126. Mithra CDMo Business Overview Table 127. Mithra CDMo Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Mithra CDMo Sterile Injectable CDMO Product Portfolio Table 129. Mithra CDMo Recent Development Table 130. S.C. Rompharm Company SRL Company Information Table 131. S.C. Rompharm Company SRL Business Overview Table 132. S.C. Rompharm Company SRL Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. S.C. Rompharm Company SRL Sterile Injectable CDMO Product Portfolio Table 134. S.C. Rompharm Company SRL Recent Development Table 135. Flagship Biotech International Pvt. Ltd Company Information Table 136. Flagship Biotech International Pvt. Ltd Business Overview Table 137. Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Product Portfolio Table 139. Flagship Biotech International Pvt. Ltd Recent Development Table 140. Curida AS Company Information Table 141. Curida AS Business Overview Table 142. Curida AS Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 143. Curida AS Sterile Injectable CDMO Product Portfolio Table 144. Curida AS Recent Development Table 145. BirgiMefar Group Company Information Table 146. BirgiMefar Group Business Overview Table 147. BirgiMefar Group Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 148. BirgiMefar Group Sterile Injectable CDMO Product Portfolio Table 149. BirgiMefar Group Recent Development Table 150. Brooks Laboratories Limited Company Information Table 151. Brooks Laboratories Limited Business Overview Table 152. Brooks Laboratories Limited Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 153. Brooks Laboratories Limited Sterile Injectable CDMO Product Portfolio Table 154. Brooks Laboratories Limited Recent Development Table 155. North America Sterile Injectable CDMO Market Size by Type (2021-2026) & (US$ Million) Table 156. North America Sterile Injectable CDMO Market Size by Type (2027-2032) & (US$ Million) Table 157. North America Sterile Injectable CDMO Market Size by Application (2021-2026) & (US$ Million) Table 158. North America Sterile Injectable CDMO Market Size by Application (2027-2032) & (US$ Million) Table 159. North America Sterile Injectable CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. North America Sterile Injectable CDMO Market Size by Country (2021-2026) Table 161. North America Sterile Injectable CDMO Market Size by Country (2027-2032) Table 162. Europe Sterile Injectable CDMO Market Size by Type (2021-2026) & (US$ Million) Table 163. Europe Sterile Injectable CDMO Market Size by Type (2027-2032) & (US$ Million) Table 164. Europe Sterile Injectable CDMO Market Size by Application (2021-2026) & (US$ Million) Table 165. Europe Sterile Injectable CDMO Market Size by Application (2027-2032) & (US$ Million) Table 166. Europe Sterile Injectable CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Europe Sterile Injectable CDMO Market Size by Country (2021-2026) Table 168. Europe Sterile Injectable CDMO Market Size by Country (2027-2032) Table 169. China Sterile Injectable CDMO Market Size by Type (2021-2026) & (US$ Million) Table 170. China Sterile Injectable CDMO Market Size by Type (2027-2032) & (US$ Million) Table 171. China Sterile Injectable CDMO Market Size by Application (2021-2026) & (US$ Million) Table 172. China Sterile Injectable CDMO Market Size by Application (2027-2032) & (US$ Million) Table 173. Asia Sterile Injectable CDMO Market Size by Type (2021-2026) & (US$ Million) Table 174. Asia Sterile Injectable CDMO Market Size by Type (2027-2032) & (US$ Million) Table 175. Asia Sterile Injectable CDMO Market Size by Application (2021-2026) & (US$ Million) Table 176. Asia Sterile Injectable CDMO Market Size by Application (2027-2032) & (US$ Million) Table 177. Asia Sterile Injectable CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Asia Sterile Injectable CDMO Market Size by Country (2021-2026) Table 179. Asia Sterile Injectable CDMO Market Size by Country (2027-2032) Table 180. South America, Middle East & Africa Sterile Injectable CDMO Market Size by Type (2021-2026) & (US$ Million) Table 181. South America, Middle East & Africa Sterile Injectable CDMO Market Size by Type (2027-2032) & (US$ Million) Table 182. South America, Middle East & Africa Sterile Injectable CDMO Market Size by Application (2021-2026) & (US$ Million) Table 183. South America, Middle East & Africa Sterile Injectable CDMO Market Size by Application (2027-2032) & (US$ Million) Table 184. South America, Middle East & Africa Sterile Injectable CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. South America, Middle East & Africa Sterile Injectable CDMO Market Size by Country (2021-2026) Table 186. South America, Middle East & Africa Sterile Injectable CDMO Market Size by Country (2027-2032) Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Sterile Injectable CDMO Product Image Figure 2. Global Sterile Injectable CDMO Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Sterile Injectable CDMO Market Share by Type: 2025 VS 2032 Figure 4. Preclinical Manufacturing Image Figure 5. Clinical Manufacturing Image Figure 6. Commercial Manufacturing Image Figure 7. Global Sterile Injectable CDMO Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Sterile Injectable CDMO Market Share by Application: 2025 VS 2032 Figure 9. Pharmaceutical Company Image Figure 10. Research Institute Image Figure 11. Other Image Figure 12. Global Sterile Injectable CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 14. Global Sterile Injectable CDMO Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Sterile Injectable CDMO Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Sterile Injectable CDMO Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Sterile Injectable CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Sterile Injectable CDMO Revenue Market Share by Type (2021-2032) Figure 21. Global Sterile Injectable CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Sterile Injectable CDMO Revenue Market Share by Application (2021-2032) Figure 23. North America Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 24. North America Sterile Injectable CDMO Market Share by Type (2021-2032) Figure 25. North America Sterile Injectable CDMO Market Share by Application (2021-2032) Figure 26. North America Sterile Injectable CDMO Market Share by Country (2021-2032) Figure 27. United States Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 28. Canada Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 30. Europe Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 31. Europe Sterile Injectable CDMO Market Share by Type (2021-2032) Figure 32. Europe Sterile Injectable CDMO Market Share by Application (2021-2032) Figure 33. Europe Sterile Injectable CDMO Market Share by Country (2021-2032) Figure 34. Germany Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 35. France Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 37. Italy Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 38. Russia Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 40. China Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 41. China Sterile Injectable CDMO Market Share by Type (2021-2032) Figure 42. China Sterile Injectable CDMO Market Share by Application (2021-2032) Figure 43. Asia Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 44. Asia Sterile Injectable CDMO Market Share by Type (2021-2032) Figure 45. Asia Sterile Injectable CDMO Market Share by Application (2021-2032) Figure 46. Asia Sterile Injectable CDMO Market Share by Country (2021-2032) Figure 47. Japan Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 51. India Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 52. Australia Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Sterile Injectable CDMO Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Sterile Injectable CDMO Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Sterile Injectable CDMO Market Share by Country (2021-2032) Figure 57. Brazil Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 62. UAE Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 64. Chile Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical Manufacturing
  • Clinical Manufacturing
  • Commercial Manufacturing
Applications
  • Pharmaceutical Company
  • Research Institute
  • Other
Companies covered
  • Abbvie
  • Famar
  • Polfa Tarchomin
  • Pfizer
  • Quotient Sciences
  • Temad Co.
  • Tianjin Hankang Pharmaceutical Biotechnology
  • Fareva
  • Sharp
  • Astral SteriTech
  • Evonik
  • Aurigene Pharmaceutical Services
  • Prague Scientific
  • Ethypharm
  • TriRx Pharmaceutical Services
  • Biophrama Group
  • Gensenta Pharmaceuticals
  • BioTechnique
  • Mithra CDMo
  • S.C. Rompharm Company SRL
  • Flagship Biotech International Pvt. Ltd
  • Curida AS
  • BirgiMefar Group
  • Brooks Laboratories Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Sterile Injectable CDMO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Preclinical Manufacturing
  5. 1.2.3 Clinical Manufacturing
  6. 1.2.4 Commercial Manufacturing
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Sterile Injectable CDMO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical Company
  10. 1.3.3 Research Institute
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Sterile Injectable CDMO Growth Trends by Region
  14. 1.5.1 Global Sterile Injectable CDMO Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Sterile Injectable CDMO Market Size by Region (2021-2026)
  16. 1.5.3 Sterile Injectable CDMO Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Sterile Injectable CDMO Market Dynamics
  1. 2.1 Sterile Injectable CDMO Industry Trends
  2. 2.2 Sterile Injectable CDMO Industry Drivers
  3. 2.3 Sterile Injectable CDMO Industry Opportunities and Challenges
  4. 2.4 Sterile Injectable CDMO Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Sterile Injectable CDMO Revenue by Company (2021-2026)
  2. 3.2 Global Sterile Injectable CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Sterile Injectable CDMO Key Company Head office and Area Served
  4. 3.4 Global Sterile Injectable CDMO Company, Product Type & Application
  5. 3.5 Global Sterile Injectable CDMO Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Sterile Injectable CDMO Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Sterile Injectable CDMO Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Sterile Injectable CDMO Tier 1, Tier 2, and Tier 3
4 Sterile Injectable CDMO Market by Type
  1. 4.1 Global Sterile Injectable CDMO Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Sterile Injectable CDMO Market Size by Type (2021-2032)
  3. 4.3 Global Sterile Injectable CDMO Market Size Share by Type (2021-2032)
5 Sterile Injectable CDMO Market by Application
  1. 5.1 Global Sterile Injectable CDMO Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Sterile Injectable CDMO Market Size by Application (2021-2032)
  3. 5.3 Global Sterile Injectable CDMO Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbvie
  2. 6.1.1 Abbvie Company Information
  3. 6.1.2 Abbvie Business Overview
  4. 6.1.3 Abbvie Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abbvie Sterile Injectable CDMO Product Portfolio
  6. 6.1.5 Abbvie Recent Developments
  7. 6.2 Famar
  8. 6.2.1 Famar Company Information
  9. 6.2.2 Famar Business Overview
  10. 6.2.3 Famar Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Famar Sterile Injectable CDMO Product Portfolio
  12. 6.2.5 Famar Recent Developments
  13. 6.3 Polfa Tarchomin
  14. 6.3.1 Polfa Tarchomin Company Information
  15. 6.3.2 Polfa Tarchomin Business Overview
  16. 6.3.3 Polfa Tarchomin Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Polfa Tarchomin Sterile Injectable CDMO Product Portfolio
  18. 6.3.5 Polfa Tarchomin Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Sterile Injectable CDMO Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Quotient Sciences
  26. 6.5.1 Quotient Sciences Company Information
  27. 6.5.2 Quotient Sciences Business Overview
  28. 6.5.3 Quotient Sciences Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Quotient Sciences Sterile Injectable CDMO Product Portfolio
  30. 6.5.5 Quotient Sciences Recent Developments
  31. 6.6 Temad Co.
  32. 6.6.1 Temad Co. Company Information
  33. 6.6.2 Temad Co. Business Overview
  34. 6.6.3 Temad Co. Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Temad Co. Sterile Injectable CDMO Product Portfolio
  36. 6.6.5 Temad Co. Recent Developments
  37. 6.7 Tianjin Hankang Pharmaceutical Biotechnology
  38. 6.7.1 Tianjin Hankang Pharmaceutical Biotechnology Company Information
  39. 6.7.2 Tianjin Hankang Pharmaceutical Biotechnology Business Overview
  40. 6.7.3 Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Product Portfolio
  42. 6.7.5 Tianjin Hankang Pharmaceutical Biotechnology Recent Developments
  43. 6.8 Fareva
  44. 6.8.1 Fareva Company Information
  45. 6.8.2 Fareva Business Overview
  46. 6.8.3 Fareva Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Fareva Sterile Injectable CDMO Product Portfolio
  48. 6.8.5 Fareva Recent Developments
  49. 6.9 Sharp
  50. 6.9.1 Sharp Company Information
  51. 6.9.2 Sharp Business Overview
  52. 6.9.3 Sharp Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sharp Sterile Injectable CDMO Product Portfolio
  54. 6.9.5 Sharp Recent Developments
  55. 6.10 Astral SteriTech
  56. 6.10.1 Astral SteriTech Company Information
  57. 6.10.2 Astral SteriTech Business Overview
  58. 6.10.3 Astral SteriTech Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Astral SteriTech Sterile Injectable CDMO Product Portfolio
  60. 6.10.5 Astral SteriTech Recent Developments
  61. 6.11 Evonik
  62. 6.11.1 Evonik Company Information
  63. 6.11.2 Evonik Business Overview
  64. 6.11.3 Evonik Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Evonik Sterile Injectable CDMO Product Portfolio
  66. 6.11.5 Evonik Recent Developments
  67. 6.12 Aurigene Pharmaceutical Services
  68. 6.12.1 Aurigene Pharmaceutical Services Company Information
  69. 6.12.2 Aurigene Pharmaceutical Services Business Overview
  70. 6.12.3 Aurigene Pharmaceutical Services Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Aurigene Pharmaceutical Services Sterile Injectable CDMO Product Portfolio
  72. 6.12.5 Aurigene Pharmaceutical Services Recent Developments
  73. 6.13 Prague Scientific
  74. 6.13.1 Prague Scientific Company Information
  75. 6.13.2 Prague Scientific Business Overview
  76. 6.13.3 Prague Scientific Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Prague Scientific Sterile Injectable CDMO Product Portfolio
  78. 6.13.5 Prague Scientific Recent Developments
  79. 6.14 Ethypharm
  80. 6.14.1 Ethypharm Company Information
  81. 6.14.2 Ethypharm Business Overview
  82. 6.14.3 Ethypharm Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Ethypharm Sterile Injectable CDMO Product Portfolio
  84. 6.14.5 Ethypharm Recent Developments
  85. 6.15 TriRx Pharmaceutical Services
  86. 6.15.1 TriRx Pharmaceutical Services Company Information
  87. 6.15.2 TriRx Pharmaceutical Services Business Overview
  88. 6.15.3 TriRx Pharmaceutical Services Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 TriRx Pharmaceutical Services Sterile Injectable CDMO Product Portfolio
  90. 6.15.5 TriRx Pharmaceutical Services Recent Developments
  91. 6.16 Biophrama Group
  92. 6.16.1 Biophrama Group Company Information
  93. 6.16.2 Biophrama Group Business Overview
  94. 6.16.3 Biophrama Group Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Biophrama Group Sterile Injectable CDMO Product Portfolio
  96. 6.16.5 Biophrama Group Recent Developments
  97. 6.17 Gensenta Pharmaceuticals
  98. 6.17.1 Gensenta Pharmaceuticals Company Information
  99. 6.17.2 Gensenta Pharmaceuticals Business Overview
  100. 6.17.3 Gensenta Pharmaceuticals Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Gensenta Pharmaceuticals Sterile Injectable CDMO Product Portfolio
  102. 6.17.5 Gensenta Pharmaceuticals Recent Developments
  103. 6.18 BioTechnique
  104. 6.18.1 BioTechnique Company Information
  105. 6.18.2 BioTechnique Business Overview
  106. 6.18.3 BioTechnique Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 BioTechnique Sterile Injectable CDMO Product Portfolio
  108. 6.18.5 BioTechnique Recent Developments
  109. 6.19 Mithra CDMo
  110. 6.19.1 Mithra CDMo Company Information
  111. 6.19.2 Mithra CDMo Business Overview
  112. 6.19.3 Mithra CDMo Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Mithra CDMo Sterile Injectable CDMO Product Portfolio
  114. 6.19.5 Mithra CDMo Recent Developments
  115. 6.20 S.C. Rompharm Company SRL
  116. 6.20.1 S.C. Rompharm Company SRL Company Information
  117. 6.20.2 S.C. Rompharm Company SRL Business Overview
  118. 6.20.3 S.C. Rompharm Company SRL Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 S.C. Rompharm Company SRL Sterile Injectable CDMO Product Portfolio
  120. 6.20.5 S.C. Rompharm Company SRL Recent Developments
  121. 6.21 Flagship Biotech International Pvt. Ltd
  122. 6.21.1 Flagship Biotech International Pvt. Ltd Company Information
  123. 6.21.2 Flagship Biotech International Pvt. Ltd Business Overview
  124. 6.21.3 Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Product Portfolio
  126. 6.21.5 Flagship Biotech International Pvt. Ltd Recent Developments
  127. 6.22 Curida AS
  128. 6.22.1 Curida AS Company Information
  129. 6.22.2 Curida AS Business Overview
  130. 6.22.3 Curida AS Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Curida AS Sterile Injectable CDMO Product Portfolio
  132. 6.22.5 Curida AS Recent Developments
  133. 6.23 BirgiMefar Group
  134. 6.23.1 BirgiMefar Group Company Information
  135. 6.23.2 BirgiMefar Group Business Overview
  136. 6.23.3 BirgiMefar Group Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 BirgiMefar Group Sterile Injectable CDMO Product Portfolio
  138. 6.23.5 BirgiMefar Group Recent Developments
  139. 6.24 Brooks Laboratories Limited
  140. 6.24.1 Brooks Laboratories Limited Company Information
  141. 6.24.2 Brooks Laboratories Limited Business Overview
  142. 6.24.3 Brooks Laboratories Limited Sterile Injectable CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Brooks Laboratories Limited Sterile Injectable CDMO Product Portfolio
  144. 6.24.5 Brooks Laboratories Limited Recent Developments
7 North America
  1. 7.1 North America Sterile Injectable CDMO Market Size (2021-2032)
  2. 7.2 North America Sterile Injectable CDMO Market Size by Type
  3. 7.2.1 North America Sterile Injectable CDMO Market Size by Type (2021-2026)
  4. 7.2.2 North America Sterile Injectable CDMO Market Size by Type (2027-2032)
  5. 7.2.3 North America Sterile Injectable CDMO Market Share by Type (2021-2032)
  6. 7.3 North America Sterile Injectable CDMO Market Size by Application
  7. 7.3.1 North America Sterile Injectable CDMO Market Size by Application (2021-2026)
  8. 7.3.2 North America Sterile Injectable CDMO Market Size by Application (2027-2032)
  9. 7.3.3 North America Sterile Injectable CDMO Market Share by Application (2021-2032)
  10. 7.4 North America Sterile Injectable CDMO Market Size by Country
  11. 7.4.1 North America Sterile Injectable CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Sterile Injectable CDMO Market Size by Country (2021-2026)
  13. 7.4.3 North America Sterile Injectable CDMO Market Size by Country (2027-2032)
  14. 7.4.4 North America Sterile Injectable CDMO Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Sterile Injectable CDMO Market Size (2021-2032)
  2. 8.2 Europe Sterile Injectable CDMO Market Size by Type
  3. 8.2.1 Europe Sterile Injectable CDMO Market Size by Type (2021-2026)
  4. 8.2.2 Europe Sterile Injectable CDMO Market Size by Type (2027-2032)
  5. 8.2.3 Europe Sterile Injectable CDMO Market Share by Type (2021-2032)
  6. 8.3 Europe Sterile Injectable CDMO Market Size by Application
  7. 8.3.1 Europe Sterile Injectable CDMO Market Size by Application (2021-2026)
  8. 8.3.2 Europe Sterile Injectable CDMO Market Size by Application (2027-2032)
  9. 8.3.3 Europe Sterile Injectable CDMO Market Share by Application (2021-2032)
  10. 8.4 Europe Sterile Injectable CDMO Market Size by Country
  11. 8.4.1 Europe Sterile Injectable CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Sterile Injectable CDMO Market Size by Country (2021-2026)
  13. 8.4.3 Europe Sterile Injectable CDMO Market Size by Country (2027-2032)
  14. 8.4.4 Europe Sterile Injectable CDMO Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Sterile Injectable CDMO Market Size (2021-2032)
  2. 9.2 China Sterile Injectable CDMO Market Size by Type
  3. 9.2.1 China Sterile Injectable CDMO Market Size by Type (2021-2026)
  4. 9.2.2 China Sterile Injectable CDMO Market Size by Type (2027-2032)
  5. 9.2.3 China Sterile Injectable CDMO Market Share by Type (2021-2032)
  6. 9.3 China Sterile Injectable CDMO Market Size by Application
  7. 9.3.1 China Sterile Injectable CDMO Market Size by Application (2021-2026)
  8. 9.3.2 China Sterile Injectable CDMO Market Size by Application (2027-2032)
  9. 9.3.3 China Sterile Injectable CDMO Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Sterile Injectable CDMO Market Size (2021-2032)
  2. 10.2 Asia Sterile Injectable CDMO Market Size by Type
  3. 10.2.1 Asia Sterile Injectable CDMO Market Size by Type (2021-2026)
  4. 10.2.2 Asia Sterile Injectable CDMO Market Size by Type (2027-2032)
  5. 10.2.3 Asia Sterile Injectable CDMO Market Share by Type (2021-2032)
  6. 10.3 Asia Sterile Injectable CDMO Market Size by Application
  7. 10.3.1 Asia Sterile Injectable CDMO Market Size by Application (2021-2026)
  8. 10.3.2 Asia Sterile Injectable CDMO Market Size by Application (2027-2032)
  9. 10.3.3 Asia Sterile Injectable CDMO Market Share by Application (2021-2032)
  10. 10.4 Asia Sterile Injectable CDMO Market Size by Country
  11. 10.4.1 Asia Sterile Injectable CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Sterile Injectable CDMO Market Size by Country (2021-2026)
  13. 10.4.3 Asia Sterile Injectable CDMO Market Size by Country (2027-2032)
  14. 10.4.4 Asia Sterile Injectable CDMO Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Sterile Injectable CDMO Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Sterile Injectable CDMO Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Sterile Injectable CDMO Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Sterile Injectable CDMO Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Sterile Injectable CDMO Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Sterile Injectable CDMO Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Sterile Injectable CDMO Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Sterile Injectable CDMO Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Sterile Injectable CDMO Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Sterile Injectable CDMO Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Sterile Injectable CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Sterile Injectable CDMO Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Sterile Injectable CDMO Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Sterile Injectable CDMO Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst